Zephyr is the developer of the MatRx and MatRx Plus obstructive sleep apnea (OSA) testing systems. These systems can be used to determine which patients will respond to treatment with oral appliances before the patient undertakes the treatment. Oral appliances only treat about 60% of OSA patients, according to the company.
The partnership will see Zephyr's OSA-detecting systems integrated into existing Dentsply Sirona products. Dentsply Sirona has also invested in Zephyr Sleep Technologies.
Copyright © 2017 DrBicuspid.com